rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    GLSI
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Greenwich LifeSciences: Buy Due To GLSI-100 BC Population Expansion And More

      Analyst rates Greenwich LifeSciences, Inc., a Buy: open-label data showed 70%-80% lower recurrence in 250 non-HLA-A*02 patients, backing Phase 3 expansion.

      8h agoSeeking AlphaGLSI
      Greenwich LifeSciences jumps on upcoming poster presentations on cancer trial
      Nov 17Seeking AlphaGLSI
      Greenwich LifeSciences Gears Up For Two Breast Cancer Vaccine Presentations — Retail Says ‘Peptide Vaccine Works’ After SLS Trial Success
      Nov 17Yahoo FinanceGLSI
      Greenwich LifeSciences Announces Acceptance of Abstracts at SABCS 2026
      Nov 17Yahoo FinanceGLSI
      Greenwich LifeSciences Interview to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
      Nov 13Yahoo FinanceGLSI
      3 Clinical-Stage Cancer Stocks With Pristine Balance Sheets

      Rising rates raise the bar for risky science. Meet three clinical-stage cancer stocks with pristine, debt-free balance sheets, plus the screener that surfaces the rest.

      Sep 16Yahoo FinanceGLSIONCY
      Why is Greenwich LifeSciences stock rallying today?
      Aug 21Investing.comGLSI

      This is the newest page. Registered accounts read further back.